Literature DB >> 21074771

Age and coumarin-type anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: a large histopathological study in carotid and femoral plaques.

Wouter J M Derksen1, Wouter Peeters, Claudia Tersteeg, Jean-Paul P M de Vries, Dominique P V de Kleijn, Frans L Moll, Allard C van der Wal, Gerard Pasterkamp, Aryan Vink.   

Abstract

INTRODUCTION: Intraplaque hemorrhage (IPH) is an important determinant of progression and destabilization of atherosclerotic plaque. We recently demonstrated that IPH is an independent predictor of future cardiovascular events after carotid endarterectomy. Thus far, it is unknown whether clinical patient characteristics, such as medication use, are associated with the occurrence of IPH. The purpose of this study was to examine the association of IPH with clinical patient characteristics. METHODS AND
RESULTS: 1070 consecutive patients who underwent a carotid (n=794) or femoral (n=276) endarterectomy were included. Endarterectomy specimens were subjected to histopathological examination. IPH was observed in 644/794 (81%) carotid and 175/276 (63%) femoral plaques. Carotid IPH was positively correlated with advanced age (69 years [IQR: 62-75] vs. 65 years [IQR: 57-73]; P=0.002) and coumarin-type anticoagulation use prior to operation (104/116 [90%] with coumarin derivatives vs. 540/678 [80%] without coumarin derivatives; P=0.01). Carotid IPH was less frequently observed in patients that used statins prior to endarterectomy (468/595 [79%] with statin vs. 176/199 [88%] without statin; P=0.002). In multivariate analysis, age, coumarin-type anticoagulation use and statin use were independently correlated with carotid IPH. No association was observed between femoral IPH and clinical patient characteristics.
CONCLUSION: Advanced age and coumarin-type anticoagulation use are associated with the occurrence of IPH, while statin use is associated with less IPH. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074771     DOI: 10.1016/j.atherosclerosis.2010.10.022

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

1.  High-resolution MRI: detection of a culprit plaque after recurrent thrombolysis.

Authors:  Laura Mechtouff; Thomas Ritzenthaler; Tae-Hee Cho; Laurent Derex; Patrick Feugier; Yves Berthezene; Diane Collet-Benzaquen; Philippe Charles Douek; Norbert Nighoghossian
Journal:  J Neurol       Date:  2015-11-03       Impact factor: 4.849

2.  10-years experience with the Athero-Express study.

Authors:  Willem E Hellings; Frans L Moll; Dominique P V de Kleijn; Gerard Pasterkamp
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

3.  Total burden of intraplaque hemorrhage in coronary arteries relates to the use of coumarin-type anticoagulants but not platelet aggregation inhibitors.

Authors:  Xiaofei Li; Aryan Vink; Hans W M Niessen; Jesper Kers; Onno J de Boer; Hanneke J P Ploegmakers; Jan G P Tijssen; Robbert J de Winter; Allard C van der Wal
Journal:  Virchows Arch       Date:  2014-09-23       Impact factor: 4.064

4.  Blood Pressure Is a Major Modifiable Risk Factor Implicated in Pathogenesis of Intraplaque Hemorrhage: An In Vivo Magnetic Resonance Imaging Study.

Authors:  Jie Sun; Gador Canton; Niranjan Balu; Daniel S Hippe; Dongxiang Xu; Jin Liu; Thomas S Hatsukami; Chun Yuan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-04       Impact factor: 8.311

Review 5.  Intraplaque haemorrhages as the trigger of plaque vulnerability.

Authors:  Jean-Baptiste Michel; Renu Virmani; Eloïsa Arbustini; Gerard Pasterkamp
Journal:  Eur Heart J       Date:  2011-03-12       Impact factor: 29.983

Review 6.  Plaque hemorrhage in carotid artery disease: pathogenesis, clinical and biomechanical considerations.

Authors:  Zhongzhao Teng; Umar Sadat; Adam J Brown; Jonathan H Gillard
Journal:  J Biomech       Date:  2014-01-13       Impact factor: 2.712

7.  The coagulation system in atherothrombosis: Implications for new therapeutic strategies.

Authors:  Renske H Olie; Paola E J van der Meijden; Hugo Ten Cate
Journal:  Res Pract Thromb Haemost       Date:  2018-02-19

8.  Antithrombotic treatment is associated with intraplaque haemorrhage in the atherosclerotic carotid artery: a cross-sectional analysis of The Rotterdam Study.

Authors:  Blerim Mujaj; Daniel Bos; Taulant Muka; Aad van der Lugt; M Arfan Ikram; Meike W Vernooij; Bruno H Stricker; Oscar H Franco
Journal:  Eur Heart J       Date:  2018-09-21       Impact factor: 29.983

9.  Lower prevalence of carotid plaque hemorrhage in women, and its mediator effect on sex differences in recurrent cerebrovascular events.

Authors:  Neghal Kandiyil; Nishath Altaf; Akram A Hosseini; Shane T MacSweeney; Dorothee P Auer
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

10.  High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics.

Authors:  Tamar S Polonsky; Kiang Liu; Lu Tian; James Carr; Timothy J Carroll; Jarett Berry; Michael H Criqui; Luigi Ferrucci; Jack M Guralnik; Melina R Kibbe; Christopher M Kramer; Feiyu Li; Dongxiang Xu; Xihao Zhao; Chun Yuan; Mary M McDermott
Journal:  Atherosclerosis       Date:  2014-09-02       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.